Glioblastoma multiforme tanılı olgularda radyoterapi sonrasında tümör rekürrensi ve radyonekroz ayırımında perfüzyon MRG ve MR spektroskopinin rolü
The role of perfusion MRİ and MR spectroscopy in differentiation of tumor recurrence and radionecrosis of the patients diagnosis with glioblastoma multiforme after radyoterapi
- Tez No: 324085
- Danışmanlar: PROF. DR. MEHMET CEM ÇALLI
- Tez Türü: Tıpta Uzmanlık
- Konular: Radyoloji ve Nükleer Tıp, Radiology and Nuclear Medicine
- Anahtar Kelimeler: glioblastoma multiforme, perfusion weighted imaging, MR spectroscopy, radionecrosis, recurrence, glioblastoma multiforme, perfusion weighted imaging, MR spectroscopy, radionecrosis, recurrence
- Yıl: 2012
- Dil: Türkçe
- Üniversite: Ege Üniversitesi
- Enstitü: Tıp Fakültesi
- Ana Bilim Dalı: Radyoloji Ana Bilim Dalı
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: 68
Özet
Purpose: GBM is the most frequent primary malignant brain tumor in adults. Optimal treatment modality is postoperative radiotherapy alone or in combination with concomitant adjuvant chemotherapy after as widest as possible surgical resection. The difficulty in evaluation after RT is distinguishing residual or recurrent tumor from radionecrosis. Radionecrosis is very similar to the clinical features and natural history of recurrent tumor. Therefore, differentiation of these two entites is very important and is often difficult. Contrast-enhanced MRI is the preferred method in these patients after follow-up radiotherapy. However, this method is insufficient. The aim of this study was to determine the additional value of perfusion MRI and MR spectroscopy to contrast enhanced MRI in the differentiation of tumor recurrence and radionecrosis after radiotherapy in patients with GBM.Materials and Methods: Contrast enhanced MR, perfusion MR and MR spectroscopy imaging findings of 40 patients (24 male, 16 female) who were diagnosed as GBM and treated with surgery and radiotherapy were examined rectospectively between January 2009 and July 2012. Radionecrosis group, 14 (35%), recurrence group, 26 (65%) patients were assessed. All patients were investigated at 1.5 and 3 Tesla MR system including conventional MR, diffusion-weighted, perfusion-weighted MRI and MR spectroscopy imaging. rCBV, rCBF values of perfusion MR examination and Cho, Cr, NAA values, Cho / Cr, Cho / NAA ratios of MR spectroscopy examination were evaluated.Results: 6 of 14 cases of radionecrosis (43%) were histopatologically diagnosed. Mean time of diagnosis of radionecrosis and recurrent tumor group was 9.00 ± 6:53 months and 8.04 ± 3.93 months, respectively. Mean rCBV value was calculated 3.79 ± 2.41 in radionecrosis group and 5.46 ± 2.19 in recurrence group . Mean rCBF value was 3.21 ± 1.99 in radionecrosis group and 5.17 ± 2.41 in recurrent group. In radionecrosis group, rCBV and rCBF values were statistically significantly lower than those of recurrence group. (p = 0.032, p = 0.013). Cho / Cr ratios were 2.55 ± 1.63 in radionecrosis group and 2.52 ± 1.60 in recurrence group; Cho / NAA ratios were 4.15 ± 3.69 in radionecrosis group and 3.24 ± 2.55 in recurrent group is measured. Results of MR spectroscopy were not statistically significant different between two analysed groups.Conclusion: As a result, in our opinion, for differentiation of tumor recurrence and radionecrosis after radiotherapy in patients with GBM, perfusion MR and MR spectroscopy imaging should be performed in addition to conventional MR imaging on follow-up examinations.
Özet (Çeviri)
Purpose: GBM is the most frequent primary malignant brain tumor in adults. Optimal treatment modality is postoperative radiotherapy alone or in combination with concomitant adjuvant chemotherapy after as widest as possible surgical resection. The difficulty in evaluation after RT is distinguishing residual or recurrent tumor from radionecrosis. Radionecrosis is very similar to the clinical features and natural history of recurrent tumor. Therefore, differentiation of these two entites is very important and is often difficult. Contrast-enhanced MRI is the preferred method in these patients after follow-up radiotherapy. However, this method is insufficient. The aim of this study was to determine the additional value of perfusion MRI and MR spectroscopy to contrast enhanced MRI in the differentiation of tumor recurrence and radionecrosis after radiotherapy in patients with GBM.Materials and Methods: Contrast enhanced MR, perfusion MR and MR spectroscopy imaging findings of 40 patients (24 male, 16 female) who were diagnosed as GBM and treated with surgery and radiotherapy were examined rectospectively between January 2009 and July 2012. Radionecrosis group, 14 (35%), recurrence group, 26 (65%) patients were assessed. All patients were investigated at 1.5 and 3 Tesla MR system including conventional MR, diffusion-weighted, perfusion-weighted MRI and MR spectroscopy imaging. rCBV, rCBF values of perfusion MR examination and Cho, Cr, NAA values, Cho / Cr, Cho / NAA ratios of MR spectroscopy examination were evaluated.Results: 6 of 14 cases of radionecrosis (43%) were histopatologically diagnosed. Mean time of diagnosis of radionecrosis and recurrent tumor group was 9.00 ± 6:53 months and 8.04 ± 3.93 months, respectively. Mean rCBV value was calculated 3.79 ± 2.41 in radionecrosis group and 5.46 ± 2.19 in recurrence group . Mean rCBF value was 3.21 ± 1.99 in radionecrosis group and 5.17 ± 2.41 in recurrent group. In radionecrosis group, rCBV and rCBF values were statistically significantly lower than those of recurrence group. (p = 0.032, p = 0.013). Cho / Cr ratios were 2.55 ± 1.63 in radionecrosis group and 2.52 ± 1.60 in recurrence group; Cho / NAA ratios were 4.15 ± 3.69 in radionecrosis group and 3.24 ± 2.55 in recurrent group is measured. Results of MR spectroscopy were not statistically significant different between two analysed groups.onclusion: As a result, in our opinion, for differentiation of tumor recurrence and radionecrosis after radiotherapy in patients with GBM, perfusion MR and MR spectroscopy imaging should be performed in addition to conventional MR imaging on follow-up examinations.
Benzer Tezler
- İki ve üç boyutlu glioblastoma multiforme hücre kültürlerinde (U-87 MG, T98G) kabazitaksel'in hücresel etkilerinin karşılaştırılmalı analizi
Comparative analysis of cabazitaxel's cellular effects on two- and three-dimensional glioblastoma multiforme (U-87 MG, T98G) cell cultures
ÖZGE ÖZER
Yüksek Lisans
Türkçe
2015
BiyolojiCelal Bayar ÜniversitesiBiyoloji Ana Bilim Dalı
PROF. DR. SELİM UZUNOĞLU
- Metformin hcl/irinotekan yüklü plga nanopartiküllerinin glioblastoma multiforme üzerindeki etkilerinin in vivo ve in vitro olarak değerlendirilmesi
In vitvo and in vivo evaluati̇on of the effect of metformin hcl/irinotecan loaded plga nanoparti̇cles on glioblastoma multi̇forme
ALİ TAGHİZADEHGHALEHJOUGHİ
Doktora
Türkçe
2015
Eczacılık ve FarmakolojiAtatürk ÜniversitesiNanobilim ve Nanomühendislik Ana Bilim Dalı
PROF. DR. AHMET HACIMÜFTÜOĞLU
- Özefagus ca., serviks ca.ve glioblastome multiforme (GBM) tanılı hastaların tedavisinde kullanılan volümetrik ayarlı arc terapi (VMAT), yoğunluk ayarlı radyoterapi (IRMT) ve 3 boyutlu konformal radyoterapi (3BKRT) tedavi tekniklerinin karşılaştırılmalı değerlendirilmesi
Esophagus ca, pelvis ca and brain ca of patients diagnosed, rapidarc linear accelerator device to compare volumetric arc therapy, intensity modulated radiotherapy and conformal plans
NAFİYE KAPLAN
Yüksek Lisans
Türkçe
2015
Radyoloji ve Nükleer TıpYıldırım Beyazıt ÜniversitesiRadyoloji Ana Bilim Dalı
PROF. DR. AYTÜNÇ ATEŞ
- The investigation of the effects of mechanistic target of rapamycin inhibition and melatonin treatment on glioblastoma In Vitro
Rapamisinin mekanistik hedefinin inhibisyonu ve melatonin tedavisinin glioblastoma üzerindeki etkilerinin In Vitro araştırılması
EMAN ELSAID MAHFOUD ELBANOUNI
Yüksek Lisans
İngilizce
2024
FizyolojiYeditepe ÜniversitesiFizyoloji Ana Bilim Dalı
PROF. DR. BURCU GEMİCİ BAŞOL
DR. CİHAN SÜLEYMAN ERDOĞAN
- Ag@NP bağlı amino asitlerle modifiye edilmiş heparin türevlerinin sentezi ve farklı hücre hatlarındaki sitotoksik etkilerinin araştırılması
Synthesis of heparin derivatives modified with Ag@NP linked amino acids and investigation of their cytotoxic effects on various cell lines
MUHAMMET TURGUT